ALKS
Alkermes Plc
Price:  
29.38 
USD
Volume:  
1,591,609
Ireland | Biotechnology

Alkermes DCF Valuation - Growth Exit 5Y

57.2 %
Upside

What is the DCF valuation of Alkermes?

The Discounted Cash Flow (DCF) valuation of Alkermes Plc (ALKS) is 46.20 USD. With the latest stock price at 29.38 USD, the upside of Alkermes Plc based on DCF is 57.2%.

Is Alkermes a buy or a sell?

Based on the latest price of 29.38 USD and our DCF valuation, Alkermes Plc (ALKS) is a buy. Buying Alkermes stocks now will result in a potential gain of 57.2%.

Range Selected
WACC / Discount Rate5.8% - 8.2%7.0%
Long-term Growth Rate 2.0% - 4.0%3.0%
Fair Price31.92 - 95.5546.20
Upside8.6% - 225.2%57.2%
29.38 USD
Stock Price
46.20 USD
Fair Price
REVENUE & EXPENSES
CAPEX
D&A
WORKING CAPITAL
TERMINAL VALUE

Alkermes DCF Valuation: Revenue & Expenses Forecast

(USD in millions)Projections
12-202412-202512-202612-202712-202812-2029
Revenue1,5581,3631,4041,4421,4791,592
% Growth
6%-13%3%3%3%8%
Cost of goods sold(245)(214)(221)(227)(233)(250)
% of Revenue16%16%16%16%16%16%
Selling, G&A expenses(645)(564)(581)(597)(613)(659)
% of Revenue41%41%41%41%41%41%
Research & Development(240)(210)(216)(222)(228)(245)
% of Revenue15%15%15%15%15%15%
Net interest & other expenses161414151516
% of Revenue1%1%1%1%1%1%
Tax expense(72)(63)(65)(67)(68)(74)
Tax rate16%16%16%16%16%16%
Net profit372325335344353380
% Margin24%24%24%24%24%24%